In Asian countries, the peak age for the disease is between 40 and 50 with an increasing trend in incidence and associated mortality [ 3 ].
← all excerpts
Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways.
1
—
—